NVCT · Nuvectis Pharma, Inc.
Market Cap
$797.92M
Shares
32.58M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-10 | 5,480 | $18.95 | $103,846 |
| 2026-08-06 | 1,891 | $19.26 | $36,421 |
| 2026-08-05 | 1,849 | $20.10 | $37,165 |
| 2026-08-03 | 160 | $21.52 | $3,443 |
| 2026-07-31 | 2,692 | $22.76 | $61,270 |
| 2026-07-30 | 87,059 | $20.69 | $1,801,251 |
| 2026-07-29 | 41,704 | $19.82 | $826,573 |
| 2026-07-28 | 42,370 | $19.54 | $827,910 |
| 2026-07-27 | 41,704 | $19.31 | $805,304 |
| 2026-07-24 | 30,304 | $20.15 | $610,626 |
| 2026-07-23 | 2,327 | $19.29 | $44,888 |
| 2026-07-21 | 319,403 | $18.03 | $5,758,836 |
| 2026-07-20 | 319,308 | $19.14 | $6,111,555 |
| 2026-07-17 | 319,203 | $18.60 | $5,937,176 |
| 2026-07-16 | 361,903 | $19.59 | $7,089,680 |
| 2026-07-15 | 362,004 | $18.29 | $6,621,053 |
| 2026-07-14 | 362,889 | $18.44 | $6,691,673 |
| 2026-07-13 | 364,305 | $18.35 | $6,684,997 |
| 2026-07-10 | 380,254 | $18.99 | $7,221,023 |
| 2026-07-09 | 377,160 | $18.75 | $7,071,750 |
| 2026-07-08 | 383,126 | $19.20 | $7,356,019 |
| 2026-07-07 | 405,196 | $19.63 | $7,953,997 |
| 2026-07-06 | 330,180 | $19.57 | $6,461,623 |
| 2026-07-02 | 238,656 | $19.52 | $4,658,565 |
| 2026-07-01 | 397,703 | $18.39 | $7,313,758 |
| 2026-06-30 | 43,896 | $28.53 | $1,252,353 |
| 2026-06-29 | 2,360 | $27.19 | $64,168 |
| 2026-06-26 | 18,153 | $27.87 | $505,924 |
| 2026-06-25 | 12,210 | $24.48 | $298,901 |
| 2026-06-23 | 3,403 | $16.53 | $56,252 |
| 2026-06-22 | 7,521 | $13.82 | $103,940 |
| 2026-06-17 | 1,219 | $11.94 | $14,555 |
| 2026-06-16 | 222 | $11.15 | $2,475 |
Showing 1–33 of 33 settlements
Key facts
CIK
1875558
CUSIP
67080T108
13F (30d)
58 filings
58 filers
Visit website
Investor relations